Cargando…
Comparison of Antithrombin III and Pentoxifylline Treatments in Gram Negative Sepsis Patients Developing Disseminated Intravascular Coagulation
OBJECTIVE: The aim of this study was to evaluate the effects of antithrombin III (AT III) and pentoxifylline treatments on the gram negative septic patients with disseminated intravascular coagulation (DIC). METHOD: For six days after plasma AT III activity dropped lower than 80% in Gram-patients wh...
Autores principales: | Ozden, Mesure Gul Nihan, Koksal, Guniz, Oz, Huseyin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Istanbul Medeniyet University
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433740/ https://www.ncbi.nlm.nih.gov/pubmed/32821443 http://dx.doi.org/10.5222/MMJ.2019.05935 |
Ejemplares similares
-
Antithrombin III concentrate may contribute to sepsis in nonovert disseminated intravascular coagulation
por: Saito, Noriko, et al.
Publicado: (2013) -
Relationship between protein C and antithrombin III deficiencies in sepsis without disseminated intravascular coagulation status
por: Takeda, Munekazu, et al.
Publicado: (2008) -
Efficacy of antithrombin in preclinical and clinical applications for sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki, et al.
Publicado: (2014) -
Effects of combination therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki, et al.
Publicado: (2017) -
Effect of Antithrombin III Administration on the Prognosis of Severe Trauma Patients with Disseminated Intravascular Coagulation
por: Chung, Jae Sik, et al.
Publicado: (2023)